Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06248788Completed

Salivary Immunoglobulin A (sIgA) Normal Range Study

Role: lead

NCT06092840Not ApplicableCompleted

Effect of Transform Burn on Weight Loss

Role: lead

NCT05476406Not ApplicableCompleted

Clinical Study to Evaluate the Impact of aKwa Skincare System on Skin Health

Role: lead

NCT05368909Not ApplicableCompleted

Clinical Study to Assess a Dietary Supplement on Sleep Health and Quality

Role: lead

NCT05347602Not ApplicableCompleted

Gold Factor on Knee Joint Health and Function

Role: lead

NCT05130905Not ApplicableCompleted

RiteStart Personal Nutritional Dietary Study

Role: lead

All 6 trials loaded